Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2014

Jan 3, 2014

29875_dirs_2014-01-03_a8f918b8-9350-4cac-8e49-7ab2613cab8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2014-01-02

Reporting Person: Roberts Jonathan C (EVP & President, Caremark)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-05 Common Stock G 850 $58.46 Disposed 29228.6731 Direct
2014-01-02 Common Stock M 60484 $34.42 Acquired 89785.6731 Direct
2014-01-02 Common Stock S 60484 $70.61 Disposed 29301.6731 Direct
2014-01-02 Common Stock M 101708 $28.10 Acquired 131009.6731 Direct
2014-01-02 Common Stock S 101708 $70.61 Disposed 29301.6731 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-02 Stock Option $34.42 M 60484 Disposed 2014-04-02 Common Stock (60484) Direct
2014-01-02 Stock Option $28.10 M 101708 Disposed 2016-04-01 Common Stock (101708) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (pep) 11095.1197 Direct
Common Stock (restricted) 65333 Direct
ESOP Common Stock 5097.1602 Indirect
Stock Unit 40563.4043 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Phantom Stock Credits $1.00 Common Stock (1432.6759) 1432.6759 Direct
Stock Option $41.17 2015-04-01 Common Stock (86487) 86487 Direct
Stock Option $36.23 2017-04-01 Common Stock (61196) 61196 Direct
Stock Option $34.96 2018-04-01 Common Stock (85743) 85743 Direct
Stock Option $45.07 2019-04-02 Common Stock (77639) 77639 Direct
Stock Option $54.53 2020-04-01 Common Stock (68844) 68844 Direct
Stock Option $45.93 2022-09-04 Common Stock (108870) 108870 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share.

F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share.

F4: Option became exercisable in three annual installments, commencing 4/2/2008.

F5: Option became exercisable in three annual installments, commencing 4/1/2010.

F6: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F7: Option became exercisable in three annual installments, commencing 4/1/2009.

F8: Option became exercisable in three annual installments, commencing 4/1/2011.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2012.

F10: Option became exercisable in four equal annual installments, commencing 4/2/2013.

F11: Option becomes exercisable in four equal annual installments, commencing 4/1/2014.

F12: Option becomes exercisable in three equal annual installments, commencing 9/4/2015.